Potential Glioblastoma Treatments Entering The Pivotal Phase of Evaluation

Jump Ahead to List of Trials Glioblastoma (GBM) is the most common and aggressive malignant brain tumor and, regrettably, very limited treatment options exist for these patients. The current standard-of-care for newly diagnosed patients is surgery, followed by radiation and chemotherapy (with temozolomide), and, in some cases, use of the tumor-treating-field device, Optune. If and … Continue reading Potential Glioblastoma Treatments Entering The Pivotal Phase of Evaluation